LANXESS signs contract to sell Urethane Systems business for an enterprise value of €460 m to UBE Corporation -proceeds will be used to reduce net financial debt 

Ad hoc according to Art. 17 paragraph 1 MAR

Specialty chemicals company LANXESS signed a contract to sell its Urethane Systems business to UBE Corporation on 3rd October, 2024. The enterprise value amounts to €460 m with expected proceeds of around €500 m. With this transaction LANXESS exits the last remaining polymer business.

The Urethane Systems business comprises 5 manufacturing sites globally as well as application laboratories in the USA, Europe and China. UBE Corporation will take over all operations from LANXESS with a total of around 400 employees. The Urethane Systems business generated sales of around €250 m last twelve months June 2024.

LANXESS will use the proceeds to reduce its net debt. The leverage ratio (net debt / EBITDA pre) will likely be reduced by ~0.5x.

The transaction remains subject to the approval of the relevant authorities. LANXESS expects the transaction to close in the first half of 2025.

Cologne, 3rd October 2024


Information for editors:
All LANXESS news releases and their accompanying photos can be found at http://press.lanxess.com. Recent photos of the Board of Management and other LANXESS image material are available at http://photos.lanxess.com.

You can find further information concerning LANXESS chemistry at http://lanxess.com/en/Media/Stories.

LANXESS signs contract to sell Urethane Systems business for an enterprise value of €460 m to UBE Corporation -proceeds will be used to reduce net financial debt 

MORE ABOUT THIS TOPIC

AD HOC

LANXESS exercises right to offer for the sale of its shares in Envalior in 2026

September 23, 2025
AD HOC

LANXESS: EBITDA pre exceptionals for the fourth quarter significantly above market expectation

January 20, 2025
AD HOC

LANXESS: EBITDA pre exceptionals for second quarter 2024 significantly above market expectation

July 17, 2024
AD HOC

Impairment of goodwill and adjustment of at-equity book value of minority interest in Envalior

February 27, 2024
AD HOC

LANXESS adjusts expectations FY 2023; Board of Management proposes dividend reduction

November 06, 2023